Skip to main content
. 2010 Nov 23;2(1):3–11. doi: 10.3892/ol.2010.212

Table III.

Assessment of response to capecitabine chemotherapy and a FOLFIRI regimen in patients above 65 years of age (n=123)a.

Capecitabine (n=56) FOLFIRI (n=67)


n % n % χ2 p-value
Overall responseb 8 16.4 18 28.1 2.18 0.1398
Complete response 2 4.1 6 9.4 0.51c 0.4733c
Partial response 6 12.3 12 18.7 0.88 0.3491
Stable disease 28 57.1 35 54.7 0.07 0.7945
Progressive disease 13 26.5 12 17.2 1.45 0.2288
Not evaluable 7 12.5 2 3.0
a

Based on the results by Stec et al (10).

b

Complete plus partial response.

c

Values calculated by the Chi-square (χ2) test with Yates correction.

FOLFIRI, 5-fluorouracil, leucovorin and irinotecan.